4
Changes in Ownership
Axogen, Inc. Filed Acc 0000805928-25-000166
Director sold 25,108 shares at $30.98 ($777,771)
- Director acquired 25,108 shares (option exercise)
From the SEC's structured data for this filing
Trades in this filing
Table I: Non-derivative
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| TYNDALL JOSEPH A. Director | 2025-12-09 | Option exercise | +14,248 | $7.04 | $100,306 | 14,248 | D: show line 1 in the form |
| TYNDALL JOSEPH A. Director | 2025-12-09 | Option exercise | +10,860 | $10.95 | $118,917 | 25,108 | D: show line 2 in the form |
| TYNDALL JOSEPH A. Director | 2025-12-09 | Sale | −14,248 | $30.98 | $441,360 | 10,860 | D: show line 3 in the form |
| TYNDALL JOSEPH A. Director | 2025-12-09 | Sale | −10,860 | $30.98 | $336,410 | 0 | D: show line 4 in the form |
| Open-market sales · 25,108 sh · avg $30.98 · $777,771 | |||||||
Table II: Derivative
| Insider | Date | Transaction | Shares | Price | Value | Exercise | Expires | Underlying | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|
| TYNDALL JOSEPH A. Director | 2025-12-09 | Option exercise · Employee Stock Option (right to purchase) | −14,248 | 0 | D: show line 5 in the form | |||||
| TYNDALL JOSEPH A. Director | 2025-12-09 | Option exercise · Stock Option (right to purchase) | −10,860 | 32,311 | D: show line 6 in the form |
Loading xslF345X05/wk-form4_1765405243.xml…